Cardiovascular Efficacy of Lipid-Lowering Drug Targets Is Not Entirely Explained by Apolipoprotein B Reduction: Mendelian Randomization Evidence

被引：0
作者：
Gill, Dipender [1 ,2 ]
Woolf, Benjamin [3 ,4 ,5 ]
Zagkos, Loukas [1 ]
Cronje, Helene T. [6 ]
Tzoulaki, Ioanna [1 ,2 ,7 ]
机构：
[1] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England
[2] Imperial Coll London, Sch Publ Hlth, British Heart Fdn Ctr Excellence, London, England
[3] Univ Bristol, Sch Psychol Sci, Bristol, England
[4] Univ Bristol, Med Res Council Integrat Epidemiol Unit, Bristol, England
[5] Univ Cambridge, Med Res Council Biostat Unit, Cambridge, England
[6] Univ Copenhagen, Dept Publ Hlth, Sect Epidemiol, Copenhagen, Denmark
[7] Biomed Res Fdn Acad Athens, Ctr Syst Biol, Athens, Greece
来源：
CIRCULATION-GENOMIC AND PRECISION MEDICINE | 2023年 / 16卷 / 05期
关键词：
apolipoprotein B; biomarker; coronary artery disease; Mendelian randomization; triglycerides;
D O I：
10.1161/CIRCGEN.123.004204
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：490 / 492
页数：3
相关论文
共 5 条
  • [1] Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease
    Ference, Brian A.
    Kastelein, John J. P.
    Ray, Kausik K.
    Ginsberg, Henry N.
    Chapman, John
    Packard, Chris J.
    Laufs, Ulrich
    Oliver-Williams, Clare
    Wood, Angela M.
    Butterworth, Adam S.
    Di Angelantonio, Emanuele
    Danesh, John
    Nicholls, Stephen J.
    Bhatt, Deepak L.
    Sabatine, Marc S.
    Catapano, Alberico L.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (04): : 364 - 373
  • [2] The power of genetic diversity in genome-wide association studies of lipids
    Graham, Sarah E.
    Clarke, Shoa L.
    Wu, Kuan-Han H.
    Kanoni, Stavroula
    Zajac, Greg J. M.
    Ramdas, Shweta
    Surakka, Ida
    Ntalla, Ioanna
    Vedantam, Sailaja
    Winkler, Thomas W.
    Locke, Adam E.
    Marouli, Eirini
    Hwang, Mi Yeong
    Han, Sohee
    Narita, Akira
    Choudhury, Ananyo
    Bentley, Amy R.
    Ekoru, Kenneth
    Verma, Anurag
    Trivedi, Bhavi
    Martin, Hilary C.
    Hunt, Karen A.
    Hui, Qin
    Klarin, Derek
    Zhu, Xiang
    Thorleifsson, Gudmar
    Helgadottir, Anna
    Gudbjartsson, Daniel F.
    Holm, Hilma
    Olafsson, Isleifur
    Akiyama, Masato
    Sakaue, Saori
    Terao, Chikashi
    Kanai, Masahiro
    Zhou, Wei
    Brumpton, Ben M.
    Rasheed, Humaira
    Ruotsalainen, Sanni E.
    Havulinna, Aki S.
    Veturi, Yogasudha
    Feng, QiPing
    Rosenthal, Elisabeth A.
    Lingren, Todd
    Pacheco, Jennifer Allen
    Pendergrass, Sarah A.
    Haessler, Jeffrey
    Giulianini, Franco
    Bradford, Yuki
    Miller, Jason E.
    Campbell, Archie
    [J]. NATURE, 2021, 600 (7890) : 675 - +
  • [3] Association of Genetically Enhanced Lipoprotein Lipase-Mediated Lipolysis and Low-Density Lipoprotein Cholesterol-Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes
    Lotta, Luca A.
    Stewart, Isobel D.
    Sharp, Stephen J.
    Day, Felix R.
    Burgess, Stephen
    Luan, Jian'an
    Bowker, Nicholas
    Cai, Lina
    Li, Chen
    Wittemans, Laura B. L.
    Kerrison, Nicola D.
    Khaw, Kay-Tee
    McCarthy, Mark I.
    O'Rahilly, Stephen
    Scott, Robert A.
    Savage, David B.
    Perry, John R. B.
    Langenberg, Claudia
    Wareham, Nicholas J.
    [J]. JAMA CARDIOLOGY, 2018, 3 (10) : 957 - 966
  • [4] Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation
    Richardson, Tom G.
    Leyden, Genevieve M.
    Wang, Qin
    Bell, Joshua A.
    Elsworth, Benjamin
    Davey Smith, George
    Holmes, Michael V.
    [J]. PLOS BIOLOGY, 2022, 20 (02)
  • [5] Apolipoprotein B Particles and Cardiovascular Disease A Narrative Review
    Sniderman, Allan D.
    Thanassoulis, George
    Glavinovic, Tamara
    Navar, Ann Marie
    Pencina, Michael
    Catapano, Alberico
    Ference, Brian A.
    [J]. JAMA CARDIOLOGY, 2019, 4 (12) : 1287 - 1295
1